We are live on ! Find out more
RVPHW

Reviva Pharmaceuticals Warrants
RVPHW

Delisted

RVPHW was delisted on the 12th of December, 2025.

Back to rankings

10 hedge funds and large institutions have $2.22M invested in Reviva Pharmaceuticals Warrants in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $2.01M → $2.22M (+$209K)

17% less funds holding

Funds holding: 12 → 10 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$90K
2
ICM
Ionic Capital Management
New York
+$61K
3
Walleye Capital
Walleye Capital
New York
+$11.1K
4
Walleye Trading
Walleye Trading
New York
+$3.08K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$161K
2
GCL
Glazer Capital LLC
New York
-$94.4K
3
HF
HRT Financial
New York
-$55K
4
RCM
Rivernorth Capital Management
Florida
-$38K
5
AA
AQR Arbitrage
Connecticut
-$21.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BlueCrest Capital Management
Jersey
$620K – – –
BFM
2
Boothbay Fund Management
New York
$523K -$6.51K -14,459 -12%
ASM
3
ATW SPAC Management
New York
$523K +$48.5K +107,701 New
GCL
4
Glazer Capital LLC
New York
$244K -$94.4K -209,707 -30%
6CM
5
683 Capital Management
New York
$102K +$90K +200,000 New
AA
6
AQR Arbitrage
Connecticut
$101K -$21.5K -47,707 -19%
ICM
7
Ionic Capital Management
New York
$69K +$61K +135,481 New
Walleye Trading
8
Walleye Trading
New York
$33K +$3.08K +6,840 +12%
Walleye Capital
9
Walleye Capital
New York
$45 +$11.1K +24,664 +38%
SM
10
Sabby Management
Florida
– -$161K -350,000 Closed
HF
11
HRT Financial
New York
– -$55K -121,576 Closed
RCM
12
Rivernorth Capital Management
Florida
– -$38K -82,481 Closed
CCM
13
Context Capital Management
California
– -$18K -39,300 Closed
VF
14
Virtu Financial
New York
– -$7K -14,169 Closed
UBS Group
15
UBS Group
Switzerland
– -$5.53K -12,287 -99%

RVPHW Hedge Fund Activity: Q2 2021 in Review

10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q2 2021, worth a combined $2.22M — up 10% from $2.01M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RVPHW and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $90K. The largest seller was Sabby Management, exiting entirely with an estimated $161K sold.

  • 10 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q2 2021, down from 12 in Q1 2021.
  • Funds reported $2.22M of Reviva Pharmaceuticals Warrants stock for Q2 2021, up 10% quarter-over-quarter.
  • 3 funds opened new Reviva Pharmaceuticals Warrants positions in Q2 2021 and 5 closed out, a net change of -2 holders.
  • The largest Reviva Pharmaceuticals Warrants buyer in Q2 2021 was 683 Capital Management, an estimated $90K added.
  • The largest Reviva Pharmaceuticals Warrants seller in Q2 2021 was Sabby Management, an estimated $161K sold.

Based on aggregated 13F filings for Q2 2021.